Harvard Apparatus Regenerative Technology, Inc. (HRGN): debt financing — Harvard Apparatus Regenerative Technology enters $500K bridge note with CEO Junli He at 8% interest

Harvard Apparatus Regenerative Technology, Inc.

Bridge note for $500,000 from Chairman/CEO Junli He; 8% annual interest on 360-day basis.
Maturity on earlier of next capital raise >= $5M gross proceeds or Feb 1, 2025.
Lender has optional conversion to equity in any Qualified Financing of $500K+ (excluding this note).
Prepayment permitted without penalty; events of default include bankruptcy, non-payment, breach of covenants.
Proceeds provide near-term working capital; insider loan aligns interests but adds related-party exposure.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Harvard Apparatus Regenerative Technology, Inc. incurred loan of $500,000 with Junli He at 8% maturing on the earlier to occur of a) the closing date (or later date of capital being provided pertaining to such continued offering that the following threshold is tr.

Instrument: loan
Principal: $500,000
Counterparty: Junli He
Rate: 8%
Maturity: on the earlier to occur of a) the closing date (or later date of capital being provided pertaining to such continued offering that the following threshold is tr
Event: incurrence

Exact text from the filing

On February 1, 2024, Harvard Apparatus Regenerative Technology, Inc. (the “ Company ”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “ Lender ”), pursuant to which the Lender has agreed to loan the Company an aggregate amount of $500,000 as evidenced by a Bridge Note executed by the Company in favor of, and accepted by, the Lender (the “ Bridge Note ”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.4

Harvard Apparatus Regenerative Technology, Inc. entered into Bridge Note with Junli He valued at $500,000 (effective 2024-02-01).

Action: entry
Counterparty: Junli He
Value: $500,000
Effective: 2024-02-01

Exact text from the filing

On February 1, 2024, Harvard Apparatus Regenerative Technology, Inc. (the “ Company ”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “ Lender ”), pursuant to which the Lender has agreed to loan the Company an aggregate amount of $500,000 as evidenced by a Bridge Note executed by the Company in favor of, and accepted by, the Lender (the “ Bridge Note ”).

View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

Harvard Apparatus Regenerative Technology, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-005102

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.